The global hyaluronic viscosupplementation market was valued at USD 2.3 Billion in 2022 and is expected to reach USD 4.0 Billion by 2033.
The three injection knee hyaluronic acid injections with around 49.1% in terms of value share, has topped the global Market within the product category in 2022 and is expected to grow at a CAGR of close to 5.2% over the forecast period (2023 to 2033)
Market Outlook:
| Data Points | Market Insights |
|---|---|
| Market Value 2022 | USD 2.3 Billion |
| Market Value 2023 | USD 2.4 Billion |
| Market Value 2033 | USD 4.0 Billion |
| CAGR 2023 to 2033 | 5.2% |
| Market Share of Top 5 Countries | 73.2% |
| Key Market Players | Anika Therapeutics Inc.; Zimmer Biomet; Sanofi S.A.; LG Chem; Chugai Pharmaceutical Co.; Ltd.; Meiji Seika Pharma co. ltd; Ferring B.V.; Hanmi Pharm.Co.;Ltd.; Anika Therapeutics; Inc.; Fidia Farmaceutici s.p.a.; Bioventus LLC; OrthogenRx; Seikagaku Corporation; Bioiberica S.A.U.; APTISSEN; Hangzhou Singclean Medical Products Co.;Ltd; Maxigen Biotech Inc.; TRB Chemedica International SA; Yuria-Pharm LLC; Haohai Biological Technology; and Chroma Pharma |
The injection of exogenous hyaluronic acid into diarthrodial joints restores synovial fluid characteristics, generating mechanical, analgesic, anti-inflammatory, and chondroprotective benefits. Hyaluronic acid is a polymer with a high viscosity and spatial structure. Rapid rehabilitation using hyaluronic acid filler offers relief from knee osteoarthritis, benefiting rheumatologists, rehabilitation providers, and primary care providers.
The global market for hyaluronic viscosupplementation was around 24.4% of the overall USD 9.56 Billion of the global hyaluronic acid based products market in 2022.
Knee osteoarthritis is a chronic degenerative condition that affects the structure of the joints and causes inflammation, leading to joint discomfort and functional restrictions. Significant population globally suffers from osteoarthritis, a multifactorial origin joint disease, with high prevalence in adults.
Because of its low allergic reaction rate, simplicity of injection, speedy recovery, repeatability, and quick effects, hyaluronic acid filler has gained popularity. Hyaluronic acid injections into the joints are another common procedure, particularly for individuals with osteoarthritis of the knees.
In light of doctors' general reluctance to provide repeated injection of intra-articular corticosteroid injections, hyaluronic acid injection as a non-surgical therapeutic option have gained large popularity.
Owed to the above factors, the global market is projected to grow at CAGR of 5.2% in forecasted period.
Viscosupplementation offers a structural benefit in knee osteoarthritis treatment, with improved visual appearance and increased cartilage volume. One year after treatment, joint surface reconstitutes, with reduced loss of joint space. This results in a cost-effectiveness relationship and potential delay in total knee arthroplasty.
First-line therapy for OA focuses on joint preservation and alleviating symptoms. Intra-articular hyaluronic acid injections (IAHA) are a promising nonsurgical treatment, particularly for mild-to-moderate OA and severe OA with comorbidities.
IAHA, a nonsurgical treatment modality, has gained popularity in managing knee OA, despite the lack of established disease-modifying treatments. Surgical methods for total knee replacement (TKR) are successful, although they have a risk-benefit ratio. Although intra-articular hyaluronic acid (IAHA) therapy or viscosupplementation have grown in recognition, there isn't enough solid research to back up their efficacy and safety.
IAHA gives patients with knee OA a little clinical benefit without safety issues, whereas viscosupplementation has a substantial benefit-to-risk ratio and speeds up TKR. IAHA improves knee OA by allowing lubrication, shock absorption, and re-establishing joint homeostasis through induction of endogenous HA production. It reduces analgesic usage to half and leads to a 40-month improvement in pain and joint function.
Price and synthesis of HA products vary, with some made synthetically through biotechnology, while others are derived from animals. These differences impact the healthcare system's economic impact. Stabilized hyaluronic acid, a new generation of HA preparations, offers a long half-life and high density, reducing injections and puncture risk in osteoarthritis treatment.
Viscosupplementation saves money in the long run by postponing surgery for severe pain, allowing therapeutic prosthesis installation, and enhancing the patient's quality of life.
National and international guidelines discourage intra-articular hyaluronic acid derivatives. In countries like England, viscosupplementation is given low NHS funding priority due to the Institute's recommendation. HA injections in the knees are frequently associated with poor tolerance and failure rates, with anteromedial injections exhibiting up to 30% local reaction rates.
The efficacy of viscosupplementation is being questioned, which might be attributed to improper usage or a poorly fitted patient OA profile. A qualified expert is required for HA injection, which is difficult in a non-swollen joint. Some of research published claim hyaluronic viscosupplementation to be ineffective in osteoarthritis, these factors act as restraints for demand of hyaluronic viscosupplements.
The USA occupies 50.0% of market share in 2022 globally. As per British Medical Journal (BMJ-Clinical research ed.) 2022, Medicare, and commercial insurance companies increased viscosupplementation coverage, with hyaluronic acid injections becoming first-line treatment for knee osteoarthritis.
This makes USA prominent market for hyaluronic viscosupplementation in North America.
Japan expenditure on hyaluronic viscosupplementation in 2022 was USD 198.4 Million.
OA education, weight management, self-management, and exercise are crucial for improving knee OA. However, few patients are willing to undergo surgery, especially in Japan. Surgeons may delay surgery for elderly or unwilling patients, and there is a disconnect between physicians and patients. Improved communication between physicians and patients is needed to better understand the potential benefits of surgery. This makes Japan a Lucrative market for hyaluronic viscosupplementation market.
In 2022, the China held a significant share in the East Asia market and contributed around USD 157.8 Million. China faces a significant burden of knee osteoarthritis, affecting 250 million people worldwide and causing disability.
With a large population, more patients may require rehabilitation treatment and replacement, posing a significant public health burden for China. This makes China a large market for hyaluronic viscosupplements.
By product, three injection knee hyaluronic acid injections held 49.1% market share in world in 2022.
These injections were generally safe and showed a significant improvement in pain only at 6 months. However, more than or 5 injections were associated with a higher risk of treatment-related adverse events. Thus, demand for three injection knee hyaluronic acid injections are predicted to expand rapidly between 2023 and 2033.
Why Molecular Weight is Preferred Prominently in Hyaluronic Viscosupplementation?
The market value of high molecular weight hyaluronic viscosupplementation is USD 1.6 Billion, representing a sizable 68.8% market share in 2022. Hyaluronic acid is a high molecular weight polysaccharide used in various applications. The topic of molecular weight and hyaluronic acid's protective physicochemical functions remains controversial.
Most studies show a direct correlation between molecular weight and its effects on synoviocytes. However, some authors believe in vivo effects may differ due to excessive molecular size, preventing its ability to move from intra-articular to intercellular environments. The relationship between molecular weight and analgesia is evident in both in vitro and in vivo results, with products with molecular weight between 0.5 and 1 x 106 Da showing the best in vivo effects. Hence, high molecular weight hyaluronic viscosupplementation is preferred prominently.
By body part, the knee accounted for the prominent share in the global hyaluronic viscosupplementation market, with a revenue share of 85.2% in 2022. This segment is expected to continue holding prominent market share by the end of forecast period.
Viscosupplementation is an outpatient procedure for knees, with application method well established. Quantity and frequency depend on product characteristics and professional experience. Viscosupplementation in knee osteoarthritis has been observed to increase cartilage volume, with biopsies showing better matrix quality and increased chondrocyte density. This treatment may present a cost-effectiveness relationship, potentially reducing joint space loss.
The ambulatory surgical centers have a considerable presence in the hyaluronic viscosupplementation market, accounting for 31.7% value share in 2022, and exhibiting a high CAGR of 5.5% over the forecast period.
Pseudosepsis cases submitted to the FDA, including those involving injections of non-cross-linked hyaluronic acid, necessitate rehabilitative therapy and anti-inflammatory medications. Ambulatory surgical centers offer expert guidance and 24/7 care, benefiting end users in the hyaluronic viscosupplementation market.
Collaborations and collaborations among healthcare providers, research institutions, and technology businesses can encourage innovation and hasten hyaluronic viscosupplementation. Collaboration in research, development, and commercialization can lead to market expansion and the creation of new applications. Numerous large firms compete in the field of hyaluronic viscosupplementation. Among the well-known players in this field are:
Similarly, recent developments related to the company’s manufacturing the hyaluronic viscosupplementation injections have been tracked by the team at Future Market Insights, which are available in the full report.
| Attributes | Details |
|---|---|
| Forecast Period | 2023 to 2033 |
| Historical Data Available for | 2012 to 2022 |
| Market Analysis | USD Million for Value, Units for Volume |
| Key Regions Covered | North America; Latin America; Europe; South Asia; East Asia; Oceania; Middle East and Africa (MEA) |
| Key Countries Covered | USA, Canada, Brazil, Mexico, Argentina, Germany, Italy, France, United Kingdom, Spain, BENELUX, Russia, Nordics, China, Japan, South Korea, India, Indonesia, Thailand, Philippines, Malaysia, Australia, New Zealand, GCC countries, Türkiye, Israel, Northern Africa and South Africa. |
| Key Market Segments Covered | Product, Body Part, Molecular Weight, Indication, End User, and Region |
| Key Companies Profiled | Anika Therapeutics Inc.; Zimmer Biomet; Sanofi S.A.; LG Chem; Chugai Pharmaceutical Co., Ltd.; Meiji Seika Pharma co. ltd; Ferring B.V.; Hanmi Pharm.Co.,Ltd.; Anika Therapeutics, Inc.; Fidia Farmaceutici s.p.a.; Bioventus LLC; OrthogenRx; Seikagaku Corporation; Bioiberica S.A.U.; APTISSEN; Hangzhou Singclean Medical Products Co.,Ltd; Maxigen Biotech Inc.; TRB Chemedica International SA; Yuria-Pharm LLC; Haohai Biological Technology; Chroma Pharma |
| Report Coverage | Market Forecast, Competition Intelligence, DROT Analysis, Market Dynamics and Challenges, Strategic Growth Initiatives |
| Pricing | Available upon Request |
Table 1: Global Market Value (US$ Million) Analysis and Forecast 2012 to 2033, by Product
Table 2: Global Market Volume (Units) Analysis and Forecast 2012 to 2033, by Product
Table 3: Global Market Value (US$ Million) Analysis and Forecast 2012 to 2033, by Body Parts
Table 4: Global Market Value (US$ Million) Analysis and Forecast 2012 to 2033, by Molecular Weight
Table 5: Global Market Value (US$ Million) Analysis and Forecast 2012 to 2033, by Indication
Table 6: Global Market Value (US$ Million) Analysis and Forecast 2012 to 2033, by End User
Table 7: Global Market Value (US$ Million) Analysis and Forecast 2012 to 2033, by End Region
Table 8: North America Market Value (US$ Million) Analysis 2012 to 2022 and Forecast 2023 to 2033, by Country
Table 9: North America Market Value (US$ Million) Analysis and Forecast 2012 to 2033, by Product
Table 10: North America Market Volume (Units) Analysis and Forecast 2012 to 2033, by Product
Table 11: North America Market Value (US$ Million) Analysis and Forecast 2012 to 2033, by Body Parts
Table 12: North America Market Value (US$ Million) Analysis and Forecast 2012 to 2033, by Molecular Weight
Table 13: North America Market Value (US$ Million) Analysis and Forecast 2012 to 2033, by Indication
Table 14: North America Market Value (US$ Million) Analysis and Forecast 2012 to 2033, by End User
Table 15: Latin America Market Value (US$ Million) Analysis 2012 to 2022 and Forecast 2023 to 2033, by Country
Table 16: Latin America Market Value (US$ Million) Analysis and Forecast 2012 to 2033, by Product
Table 17: Latin America Market Volume (Units) Analysis and Forecast 2012 to 2033, by Product
Table 18: Latin America Market Value (US$ Million) Analysis and Forecast 2012 to 2033, by Body Parts
Table 19: Latin America Market Value (US$ Million) Analysis and Forecast 2012 to 2033, by Molecular Weight
Table 20: Latin America Market Value (US$ Million) Analysis and Forecast 2012 to 2033, by Indication
Table 21: Latin America Market Value (US$ Million) Analysis and Forecast 2012 to 2033, by End User
Table 22: Europe Market Value (US$ Million) Analysis 2012 to 2022 and Forecast 2023 to 2033, by Country
Table 23: Europe Market Value (US$ Million) Analysis and Forecast 2012 to 2033, by Product
Table 24: Europe Market Volume (Units) Analysis and Forecast 2012 to 2033, by Product
Table 25: Europe Market Value (US$ Million) Analysis and Forecast 2012 to 2033, by Body Parts
Table 26: Europe Market Value (US$ Million) Analysis and Forecast 2012 to 2033, by Molecular Weight
Table 27: Europe Market Value (US$ Million) Analysis and Forecast 2012 to 2033, by Indication
Table 28: Europe Market Value (US$ Million) Analysis and Forecast 2012 to 2033, by End User
Table 29: South Asia Market Value (US$ Million) Analysis 2012 to 2022 and Forecast 2023 to 2033, by Country
Table 30: South Asia Market Value (US$ Million) Analysis and Forecast 2012 to 2033, by Product
Table 31: South Asia Market Volume (Units) Analysis and Forecast 2012 to 2033, by Product
Table 32: South Asia Market Value (US$ Million) Analysis and Forecast 2012 to 2033, by Body Parts
Table 33: South Asia Market Value (US$ Million) Analysis and Forecast 2012 to 2033, by Molecular Weight
Table 34: South Asia Market Value (US$ Million) Analysis and Forecast 2012 to 2033, by Indication
Table 35: South Asia Market Value (US$ Million) Analysis and Forecast 2012 to 2033, by End User
Table 36: East Asia Market Value (US$ Million) Analysis 2012 to 2022 and Forecast 2023 to 2033, by Country
Table 37: East Asia Market Value (US$ Million) Analysis and Forecast 2012 to 2033, by Product
Table 38: East Asia Market Volume (Units) Analysis and Forecast 2012 to 2033, by Product
Table 39: East Asia Market Value (US$ Million) Analysis and Forecast 2012 to 2033, by Body Parts
Table 40: East Asia Market Value (US$ Million) Analysis and Forecast 2012 to 2033, by Molecular Weight
Table 41: East Asia Market Value (US$ Million) Analysis and Forecast 2012 to 2033, by Indication
Table 42: East Asia Market Value (US$ Million) Analysis and Forecast 2012 to 2033, by End User
Table 43: Oceania Market Value (US$ Million) Analysis 2012 to 2022 and Forecast 2023 to 2033, by Country
Table 44: Oceania Market Value (US$ Million) Analysis and Forecast 2012 to 2033, by Product
Table 45: Oceania Market Volume (Units) Analysis and Forecast 2012 to 2033, by Product
Table 46: Oceania Market Value (US$ Million) Analysis and Forecast 2012 to 2033, by Body Parts
Table 47: Oceania Market Value (US$ Million) Analysis and Forecast 2012 to 2033, by Molecular Weight
Table 48: Oceania Market Value (US$ Million) Analysis and Forecast 2012 to 2033, by Indication
Table 49: Oceania Market Value (US$ Million) Analysis and Forecast 2012 to 2033, by End User
Table 50: Middle East and Africa Market Value (US$ Million) Analysis 2012 to 2022 and Forecast 2023 to 2033, by Country
Table 51: Middle East and Africa Market Value (US$ Million) Analysis and Forecast 2012 to 2033, by Product
Table 52: Middle East and Africa Market Volume (Units) Analysis and Forecast 2012 to 2033, by Product
Table 53: Middle East and Africa Market Value (US$ Million) Analysis and Forecast 2012 to 2033, by Body Parts
Table 54: Middle East and Africa Market Value (US$ Million) Analysis and Forecast 2012 to 2033, by Molecular Weight
Table 55: Middle East and Africa Market Value (US$ Million) Analysis and Forecast 2012 to 2033, by Indication
Table 56: Middle East and Africa Market Value (US$ Million) Analysis and Forecast 2012 to 2033, by End User
Figure 1: Global Market Volume (Units), 2012 to 2022
Figure 2: Global Market Volume (Units) & Y-o-Y Growth (%) Analysis, 2023 to 2033
Figure 3: Hyaluronic Viscosupplementation, Pricing Analysis per unit (US$), in 2023
Figure 4: Hyaluronic Viscosupplementation, Pricing Forecast per unit (US$), in 2033
Figure 5: Global Market Value (US$ Million) Analysis, 2012 to 2022
Figure 6: Global Market Forecast & Y-o-Y Growth, 2023 to 2033
Figure 7: Global Market Absolute $ Opportunity (US$ Million) Analysis, 2022–2033
Figure 8: Global Market Value Share (%) Analysis 2023 to 2033, by Product
Figure 9: Global Market Y-o-Y Growth (%) Analysis 2022 to 2033, by Product
Figure 10: Global Market Attractiveness Analysis 2023 to 2033, by Product
Figure 11: Global Market Value Share (%) Analysis 2023 to 2033, by Body Parts
Figure 12: Global Market Y-o-Y Growth (%) Analysis 2022 to 2033, by Body Parts
Figure 13: Global Market Attractiveness Analysis 2023 to 2033, by Body Parts
Figure 14: Global Market Value Share (%) Analysis 2023 to 2033, by Molecular Weight
Figure 15: Global Market Y-o-Y Growth (%) Analysis 2022 to 2033, by Molecular Weight
Figure 16: Global Market Attractiveness Analysis 2023 to 2033, by Molecular Weight
Figure 17: Global Market Value Share (%) Analysis 2023 to 2033, by Indication
Figure 18: Global Market Y-o-Y Growth (%) Analysis 2022 to 2033, by Indication
Figure 19: Global Market Attractiveness Analysis 2023 to 2033, by Indication
Figure 20: Global Market Value Share (%) Analysis 2023 to 2033, by End User
Figure 21: Global Market Y-o-Y Growth (%) Analysis 2022 to 2033, by End User
Figure 22: Global Market Attractiveness Analysis 2023 to 2033, by End User
Figure 23: Global Market Value Share (%) Analysis 2023 to 2033, by Region
Figure 24: Global Market Y-o-Y Growth (%) Analysis 2022 to 2033, by Region
Figure 25: Global Market Attractiveness Analysis 2023 to 2033, by Region
Figure 26: North America Market Value (US$ Million) Analysis, 2012 to 2022
Figure 27: North America Market Value (US$ Million) Forecast, 2023 to 2033
Figure 28: North America Market Value Share, by Product (2023 E)
Figure 29: North America Market Value Share, by Body Parts (2023 E)
Figure 30: North America Market Value Share, by Molecular Weight (2023 E)
Figure 31: North America Market Value Share, by Indication (2023 E)
Figure 32: North America Market Value Share, by End User (2023 E)
Figure 33: North America Market Value Share, by Country (2023 E)
Figure 34: North America Market Attractiveness Analysis by Product, 2023 to 2033
Figure 35: North America Market Attractiveness Analysis by Body Parts, 2023 to 2033
Figure 36: North America Market Attractiveness Analysis by Molecular Weight, 2023 to 2033
Figure 37: North America Market Attractiveness Analysis by Indication, 2023 to 2033
Figure 38: North America Market Attractiveness Analysis by End User, 2023 to 2033
Figure 39: North America Market Attractiveness Analysis by Country, 2023 to 2033
Figure 40: USA. Market Value Proportion Analysis, 2022
Figure 41: Global Vs. USA. Growth Comparison, 2022 to 2033
Figure 42: USA. Market Share Analysis (%) by Product, 2022 to 2033
Figure 43: USA. Market Share Analysis (%) by Body Parts, 2022 to 2033
Figure 44: USA. Market Share Analysis (%) by Molecular Weight, 2022 to 2033
Figure 45: USA. Market Share Analysis (%) by Indication, 2022 to 2033
Figure 46: USA. Market Share Analysis (%) by End User, 2022 to 2033
Figure 47: Canada Market Value Proportion Analysis, 2022
Figure 48: Global Vs. Canada. Growth Comparison, 2022 to 2033
Figure 49: Canada Market Share Analysis (%) by Product, 2022 to 2033
Figure 50: Canada Market Share Analysis (%) by Body Parts, 2022 to 2033
Figure 51: Canada Market Share Analysis (%) by Molecular Weight, 2022 to 2033
Figure 52: Canada Market Share Analysis (%) by Indication, 2022 to 2033
Figure 53: Canada Market Share Analysis (%) by End User, 2022 to 2033
Figure 54: Latin America Market Value (US$ Million) Analysis, 2012 to 2022
Figure 55: Latin America Market Value (US$ Million) Forecast, 2023 to 2033
Figure 56: Latin America Market Value Share, by Product (2023 E)
Figure 57: Latin America Market Value Share, by Body Parts (2023 E)
Figure 58: Latin America Market Value Share, by Molecular Weight (2023 E)
Figure 59: Latin America Market Value Share, by Indication (2023 E)
Figure 60: Latin America Market Value Share, by End User (2023 E)
Figure 61: Latin America Market Value Share, by Country (2023 E)
Figure 62: Latin America Market Attractiveness Analysis by Product, 2023 to 2033
Figure 63: Latin America Market Attractiveness Analysis by Body Parts, 2023 to 2033
Figure 64: Latin America Market Attractiveness Analysis by Molecular Weight, 2023 to 2033
Figure 65: Latin America Market Attractiveness Analysis by Indication, 2023 to 2033
Figure 66: Latin America Market Attractiveness Analysis by End User, 2023 to 2033
Figure 67: Latin America Market Attractiveness Analysis by Country, 2023 to 2033
Figure 68: Brazil Market Value Proportion Analysis, 2022
Figure 69: Global Vs. Brazil. Growth Comparison, 2022 to 2033
Figure 70: Brazil Market Share Analysis (%) by Product, 2022 to 2033
Figure 71: Brazil Market Share Analysis (%) by Body Parts, 2022 to 2033
Figure 72: Brazil Market Share Analysis (%) by Molecular Weight, 2022 to 2033
Figure 73: Brazil Market Share Analysis (%) by Indication, 2022 to 2033
Figure 74: Brazil Market Share Analysis (%) by End User, 2022 to 2033
Figure 75: Mexico Market Value Proportion Analysis, 2022
Figure 76: Global Vs Mexico Growth Comparison, 2022 to 2033
Figure 77: Mexico Market Share Analysis (%) by Product, 2022 to 2033
Figure 78: Mexico Market Share Analysis (%) by Body Parts, 2022 to 2033
Figure 79: Mexico Market Share Analysis (%) by Molecular Weight, 2022 to 2033
Figure 80: Mexico Market Share Analysis (%) by Indication, 2022 to 2033
Figure 81: Mexico Market Share Analysis (%) by End User, 2022 to 2033
Figure 82: Argentina Market Value Proportion Analysis, 2022
Figure 83: Global Vs Argentina Growth Comparison, 2022 to 2033
Figure 84: Argentina Market Share Analysis (%) by Product, 2022 to 2033
Figure 85: Argentina Market Share Analysis (%) by Body Parts, 2022 to 2033
Figure 86: Argentina Market Share Analysis (%) by Molecular Weight, 2022 to 2033
Figure 87: Argentina Market Share Analysis (%) by Indication, 2022 to 2033
Figure 88: Argentina Market Share Analysis (%) by End User, 2022 to 2033
Figure 89: Europe Market Value (US$ Million) Analysis, 2012 to 2022
Figure 90: Europe Market Value (US$ Million) Forecast, 2023 to 2033
Figure 91: Europe Market Value Share, by Product (2023 E)
Figure 92: Europe Market Value Share, by Body Parts (2023 E)
Figure 93: Europe Market Value Share, by Molecular Weight (2023 E)
Figure 94: Europe Market Value Share, by Indication (2023 E)
Figure 95: Europe Market Value Share, by End User (2023 E)
Figure 96: Europe Market Value Share, by Country (2023 E)
Figure 97: Europe Market Attractiveness Analysis by Product, 2023 to 2033
Figure 98: Europe Market Attractiveness Analysis by Body Parts, 2023 to 2033
Figure 99: Europe Market Attractiveness Analysis by Molecular Weight, 2023 to 2033
Figure 100: Europe Market Attractiveness Analysis by Indication, 2023 to 2033
Figure 101: Europe Market Attractiveness Analysis by End User, 2023 to 2033
Figure 102: Europe Market Attractiveness Analysis by Country, 2023 to 2033
Figure 103: Germany Market Value Proportion Analysis, 2022
Figure 104: Global Vs. Germany Growth Comparison, 2022 to 2033
Figure 105: Germany Market Share Analysis (%) by Product, 2022 to 2033
Figure 106: Germany Market Share Analysis (%) by Body Parts, 2022 to 2033
Figure 107: Germany Market Share Analysis (%) by Molecular Weight, 2022 to 2033
Figure 108: Germany Market Share Analysis (%) by Indication, 2022 to 2033
Figure 109: Germany Market Share Analysis (%) by End User, 2022 to 2033
Figure 110: France Market Value Proportion Analysis, 2022
Figure 111: Global Vs France Growth Comparison, 2022 to 2033
Figure 112: France Market Share Analysis (%) by Product, 2022 to 2033
Figure 113: France Market Share Analysis (%) by Body Parts, 2022 to 2033
Figure 114: France Market Share Analysis (%) by Molecular Weight, 2022 to 2033
Figure 115: France Market Share Analysis (%) by Indication, 2022 to 2033
Figure 116: France Market Share Analysis (%) by End User, 2022 to 2033
Figure 117: Spain Market Value Proportion Analysis, 2022
Figure 118: Global Vs Spain Growth Comparison, 2022 to 2033
Figure 119: Spain Market Share Analysis (%) by Product, 2022 to 2033
Figure 120: Spain Market Share Analysis (%) by Body Parts, 2022 to 2033
Figure 121: Spain Market Share Analysis (%) by Molecular Weight, 2022 to 2033
Figure 122: Spain Market Share Analysis (%) by Indication, 2022 to 2033
Figure 123: Spain Market Share Analysis (%) by End User, 2022 to 2033
Figure 124: Russia Market Value Proportion Analysis, 2022
Figure 125: Global Vs Russia Growth Comparison, 2022 to 2033
Figure 126: Russia Market Share Analysis (%) by Product, 2022 to 2033
Figure 127: Russia Market Share Analysis (%) by Body Parts, 2022 to 2033
Figure 128: Russia Market Share Analysis (%) by Molecular Weight, 2022 to 2033
Figure 129: Russia Market Share Analysis (%) by Indication, 2022 to 2033
Figure 130: Russia Market Share Analysis (%) by End User, 2022 to 2033
Figure 131: Italy Market Value Proportion Analysis, 2022
Figure 132: Global Vs. Italy Growth Comparison, 2022 – 2033
Figure 133: Italy Market Share Analysis (%) by Product, 2022 to 2033
Figure 134: Italy Market Share Analysis (%) by Body Parts, 2022 to 2033
Figure 135: Italy Market Share Analysis (%) by Molecular Weight, 2022 to 2033
Figure 136: Italy Market Share Analysis (%) by Indication, 2022 to 2033
Figure 137: Italy Market Share Analysis (%) by End User, 2022 to 2033
Figure 138: BENELUX Market Value Proportion Analysis, 2022
Figure 139: Global Vs BENELUX Growth Comparison, 2022 to 2033
Figure 140: BENELUX Market Share Analysis (%) by Product, 2022 to 2033
Figure 141: BENELUX Market Share Analysis (%) by Body Parts, 2022 to 2033
Figure 142: BENELUX Market Share Analysis (%) by Molecular Weight, 2022 to 2033
Figure 143: BENELUX Market Share Analysis (%) by Indication, 2022 to 2033
Figure 144: BENELUX Market Share Analysis (%) by End User, 2022 to 2033
Figure 145: United Kingdom. Market Value Proportion Analysis, 2022
Figure 146: Global Vs. United Kingdom. Growth Comparison, 2022 to 2033
Figure 147: United Kingdom. Market Share Analysis (%) by Product, 2022 to 2033
Figure 148: United Kingdom. Market Share Analysis (%) by Body Parts, 2022 to 2033
Figure 149: United Kingdom. Market Share Analysis (%) by Molecular Weight, 2022 to 2033
Figure 150: United Kingdom. Market Share Analysis (%) by Indication, 2022 to 2033
Figure 151: United Kingdom. Market Share Analysis (%) by End User, 2022 to 2033
Figure 152: Nordics Market Value Proportion Analysis, 2022
Figure 153: Global Vs. Nordics Growth Comparison, 2022 to 2033
Figure 154: Nordics Market Share Analysis (%) by Product, 2022 to 2033
Figure 155: Nordics Market Share Analysis (%) by Body Parts, 2022 to 2033
Figure 156: Nordics Market Share Analysis (%) by Molecular Weight, 2022 to 2033
Figure 157: Nordics Market Share Analysis (%) by Indication, 2022 to 2033
Figure 158: Nordics Market Share Analysis (%) by End User, 2022 to 2033
Figure 159: East Asia Market Value (US$ Million) Analysis, 2012 to 2022
Figure 160: East Asia Market Value (US$ Million) Forecast, 2023 to 2033
Figure 161: East Asia Market Value Share, by Product (2023 E)
Figure 162: East Asia Market Value Share, by Body Parts (2023 E)
Figure 163: East Asia Market Value Share, by Molecular Weight (2023 E)
Figure 164: East Asia Market Value Share, by Indication (2023 E)
Figure 165: East Asia Market Value Share, by End User (2023 E)
Figure 166: East Asia Market Value Share, by Country (2023 E)
Figure 167: East Asia Market Attractiveness Analysis by Product, 2023 to 2033
Figure 168: East Asia Market Attractiveness Analysis by Body Parts, 2023 to 2033
Figure 169: East Asia Market Attractiveness Analysis by Molecular Weight, 2023 to 2033
Figure 170: East Asia Market Attractiveness Analysis by Indication, 2023 to 2033
Figure 171: East Asia Market Attractiveness Analysis by End User, 2023 to 2033
Figure 172: East Asia Market Attractiveness Analysis by Country, 2023 to 2033
Figure 173: China Market Value Proportion Analysis, 2022
Figure 174: Global Vs. China Growth Comparison, 2022 to 2033
Figure 175: China Market Share Analysis (%) by Product, 2022 to 2033
Figure 176: China Market Share Analysis (%) by Body Parts, 2022 to 2033
Figure 177: China Market Share Analysis (%) by Molecular Weight, 2022 to 2033
Figure 178: China Market Share Analysis (%) by Indication, 2022 to 2033
Figure 179: China Market Share Analysis (%) by End User, 2022 to 2033
Figure 180: Japan Market Value Proportion Analysis, 2022
Figure 181: Global Vs. Japan Growth Comparison, 2022 to 2033
Figure 182: Japan Market Share Analysis (%) by Product, 2022 to 2033
Figure 183: Japan Market Share Analysis (%) by Body Parts, 2022 to 2033
Figure 184: Japan Market Share Analysis (%) by Molecular Weight, 2022 to 2033
Figure 185: Japan Market Share Analysis (%) by Indication, 2022 to 2033
Figure 186: Japan Market Share Analysis (%) by End User, 2022 to 2033
Figure 187: South Korea Market Value Proportion Analysis, 2022
Figure 188: Global Vs South Korea Growth Comparison, 2022 to 2033
Figure 189: South Korea Market Share Analysis (%) by Product, 2022 to 2033
Figure 190: South Korea Market Share Analysis (%) by Body Parts, 2022 to 2033
Figure 191: South Korea Market Share Analysis (%) by Molecular Weight, 2022 to 2033
Figure 192: South Korea Market Share Analysis (%) by Indication, 2022 to 2033
Figure 193: South Korea Market Share Analysis (%) by End User, 2022 to 2033
Figure 194: South Asia Market Value (US$ Million) Analysis, 2012 to 2022
Figure 195: South Asia Market Value (US$ Million) Forecast, 2023 to 2033
Figure 196: South Asia Market Value Share, by Product (2023 E)
Figure 197: South Asia Market Value Share, by Body Parts (2023 E)
Figure 198: South Asia Market Value Share, by Molecular Weight (2023 E)
Figure 199: South Asia Market Value Share, by Indication (2023 E)
Figure 200: South Asia Market Value Share, by End User (2023 E)
Figure 201: South Asia Market Value Share, by Country (2023 E)
Figure 202: South Asia Market Attractiveness Analysis by Product, 2023 to 2033
Figure 203: South Asia Market Attractiveness Analysis by Body Parts, 2023 to 2033
Figure 204: South Asia Market Attractiveness Analysis by Molecular Weight, 2023 to 2033
Figure 205: South Asia Market Attractiveness Analysis by Indication, 2023 to 2033
Figure 206: South Asia Market Attractiveness Analysis by End User, 2023 to 2033
Figure 207: South Asia Market Attractiveness Analysis by Country, 2023 to 2033
Figure 208: India Market Value Proportion Analysis, 2022
Figure 209: Global Vs. India Growth Comparison, 2022 to 2033
Figure 210: India Market Share Analysis (%) by Product, 2022 to 2033
Figure 211: India Market Share Analysis (%) by Body Parts, 2022 to 2033
Figure 212: India Market Share Analysis (%) by Molecular Weight, 2022 to 2033
Figure 213: India Market Share Analysis (%) by Indication, 2022 to 2033
Figure 214: India Market Share Analysis (%) by End User, 2022 to 2033
Figure 215: Indonesia Market Value Proportion Analysis, 2022
Figure 216: Global Vs. Indonesia Growth Comparison, 2022 to 2033
Figure 217: Indonesia Market Share Analysis (%) by Product, 2022 to 2033
Figure 218: Indonesia Market Share Analysis (%) by Body Parts, 2022 to 2033
Figure 219: Indonesia Market Share Analysis (%) by Molecular Weight, 2022 to 2033
Figure 220: Indonesia Market Share Analysis (%) by Indication, 2022 to 2033
Figure 221: Indonesia Market Share Analysis (%) by End User, 2022 to 2033
Figure 222: Thailand Market Value Proportion Analysis, 2022
Figure 223: Global Vs. Thailand Growth Comparison, 2022 to 2033
Figure 224: Thailand Market Share Analysis (%) by Product, 2022 to 2033
Figure 225: Thailand Market Share Analysis (%) by Body Parts, 2022 to 2033
Figure 226: Thailand Market Share Analysis (%) by Molecular Weight, 2022 to 2033
Figure 227: Thailand Market Share Analysis (%) by Indication, 2022 to 2033
Figure 228: Thailand Market Share Analysis (%) by End User, 2022 to 2033
Figure 229: Philippines Market Value Proportion Analysis, 2022
Figure 230: Global Vs. Philippines Growth Comparison, 2022 to 2033
Figure 231: Philippines Market Share Analysis (%) by Product, 2022 to 2033
Figure 232: Philippines Market Share Analysis (%) by Body Parts, 2022 to 2033
Figure 233: Philippines Market Share Analysis (%) by Molecular Weight, 2022 to 2033
Figure 234: Philippines Market Share Analysis (%) by Indication, 2022 to 2033
Figure 235: Philippines Market Share Analysis (%) by End User, 2022 to 2033
Figure 236: Malaysia Market Value Proportion Analysis, 2022
Figure 237: Global Vs. Malaysia Growth Comparison, 2022 to 2033
Figure 238: Malaysia Market Share Analysis (%) by Product, 2022 to 2033
Figure 239: Malaysia Market Share Analysis (%) by Body Parts, 2022 to 2033
Figure 240: Malaysia Market Share Analysis (%) by Molecular Weight, 2022 to 2033
Figure 241: Malaysia Market Share Analysis (%) by Indication, 2022 to 2033
Figure 242: Malaysia Market Share Analysis (%) by End User, 2022 to 2033
Figure 243: Vietnam Market Value Proportion Analysis, 2022
Figure 244: Global Vs. Vietnam Growth Comparison, 2022 to 2033
Figure 245: Vietnam Market Share Analysis (%) by Product, 2022 to 2033
Figure 246: Vietnam Market Share Analysis (%) by Body Parts, 2022 to 2033
Figure 247: Vietnam Market Share Analysis (%) by Molecular Weight, 2022 to 2033
Figure 248: Vietnam Market Share Analysis (%) by Indication, 2022 to 2033
Figure 249: Vietnam Market Share Analysis (%) by End User, 2022 to 2033
Figure 250: Oceania Market Value (US$ Million) Analysis, 2012 to 2022
Figure 251: Oceania Market Value (US$ Million) Forecast, 2023 to 2033
Figure 252: Oceania Market Value Share, by Product (2023 E)
Figure 253: Oceania Market Value Share, by Body Parts (2023 E)
Figure 254: Oceania Market Value Share, by Molecular Weight (2023 E)
Figure 255: Oceania Market Value Share, by Indication (2023 E)
Figure 256: Oceania Market Value Share, by End User (2023 E)
Figure 257: Oceania Market Value Share, by Country (2023 E)
Figure 258: Oceania Market Attractiveness Analysis by Product, 2023 to 2033
Figure 259: Oceania Market Attractiveness Analysis by Body Parts, 2023 to 2033
Figure 260: Oceania Market Attractiveness Analysis by Molecular Weight, 2023 to 2033
Figure 261: Oceania Market Attractiveness Analysis by Indication, 2023 to 2033
Figure 262: Oceania Market Attractiveness Analysis by End User, 2023 to 2033
Figure 263: Oceania Market Attractiveness Analysis by Country, 2023 to 2033
Figure 264: Australia Market Value Proportion Analysis, 2022
Figure 265: Global Vs. Australia Growth Comparison, 2022 to 2033
Figure 266: Australia Market Share Analysis (%) by Product, 2022 to 2033
Figure 267: Australia Market Share Analysis (%) by Body Parts, 2022 to 2033
Figure 268: Australia Market Share Analysis (%) by Molecular Weight, 2022 to 2033
Figure 269: Australia Market Share Analysis (%) by Indication, 2022 to 2033
Figure 270: Australia Market Share Analysis (%) by End User, 2022 to 2033
Figure 271: New Zealand Market Value Proportion Analysis, 2022
Figure 272: Global Vs New Zealand Growth Comparison, 2022 to 2033
Figure 273: New Zealand Market Share Analysis (%) by Product, 2022 to 2033
Figure 274: New Zealand Market Share Analysis (%) by Body Parts, 2022 to 2033
Figure 275: New Zealand Market Share Analysis (%) by Molecular Weight, 2022 to 2033
Figure 276: New Zealand Market Share Analysis (%) by Indication, 2022 to 2033
Figure 277: New Zealand Market Share Analysis (%) by End User, 2022 to 2033
Figure 278: Middle East & Africa Market Value (US$ Million) Analysis, 2012 to 2022
Figure 279: Middle East & Africa Market Value (US$ Million) Forecast, 2023 to 2033
Figure 280: Middle East & Africa Market Value Share, by Product (2023 E)
Figure 281: Middle East & Africa Market Value Share, by Body Parts (2023 E)
Figure 282: Middle East & Africa Market Value Share, by Molecular Weight (2023 E)
Figure 283: Middle East & Africa Market Value Share, by Indication (2023 E)
Figure 284: Middle East & Africa Market Value Share, by End User (2023 E)
Figure 285: Middle East & Africa Market Value Share, by Country (2023 E)
Figure 286: Middle East & Africa Market Attractiveness Analysis by Product, 2023 to 2033
Figure 287: Middle East & Africa Market Attractiveness Analysis by Body Parts, 2023 to 2033
Figure 288: Middle East & Africa Market Attractiveness Analysis by Molecular Weight, 2023 to 2033
Figure 289: Middle East & Africa Market Attractiveness Analysis by Indication, 2023 to 2033
Figure 290: Middle East & Africa Market Attractiveness Analysis by End User, 2023 to 2033
Figure 291: Middle East & Africa Market Attractiveness Analysis by Country, 2023 to 2033
Figure 292: GCC Countries Market Value Proportion Analysis, 2022
Figure 293: Global Vs GCC Countries Growth Comparison, 2022 to 2033
Figure 294: GCC Countries Market Share Analysis (%) by Product, 2022 to 2033
Figure 295: GCC Countries Market Share Analysis (%) by Body Parts, 2022 to 2033
Figure 296: GCC Countries Market Share Analysis (%) by Molecular Weight, 2022 to 2033
Figure 297: GCC Countries Market Share Analysis (%) by Indication, 2022 to 2033
Figure 298: GCC Countries Market Share Analysis (%) by End User, 2022 to 2033
Figure 299: Türkiye Market Value Proportion Analysis, 2022
Figure 300: Global Vs. Türkiye Growth Comparison, 2022 to 2033
Figure 301: Türkiye Market Share Analysis (%) by Product, 2022 to 2033
Figure 302: Türkiye Market Share Analysis (%) by Body Parts, 2022 to 2033
Figure 303: Türkiye Market Share Analysis (%) by Molecular Weight, 2022 to 2033
Figure 304: Türkiye Market Share Analysis (%) by Indication, 2022 to 2033
Figure 305: Türkiye Market Share Analysis (%) by End User, 2022 to 2033
Figure 306: Israel Market Value Proportion Analysis, 2022
Figure 307: Global Vs. Israel Growth Comparison, 2022 to 2033
Figure 308: Israel Market Share Analysis (%) by Product, 2022 to 2033
Figure 309: Israel Market Share Analysis (%) by Body Parts, 2022 to 2033
Figure 310: Israel Market Share Analysis (%) by Molecular Weight, 2022 to 2033
Figure 311: Israel Market Share Analysis (%) by Indication, 2022 to 2033
Figure 312: Israel Market Share Analysis (%) by End User, 2022 to 2033
Figure 313: South Africa Market Value Proportion Analysis, 2022
Figure 314: Global Vs. South Africa Growth Comparison, 2022 to 2033
Figure 315: South Africa Market Share Analysis (%) by Product, 2022 to 2033
Figure 316: South Africa Market Share Analysis (%) by Body Parts, 2022 to 2033
Figure 317: South Africa Market Share Analysis (%) by Molecular Weight, 2022 to 2033
Figure 318: South Africa Market Share Analysis (%) by Indication, 2022 to 2033
Figure 319: South Africa Market Share Analysis (%) by End User, 2022 to 2033
Figure 320: Northern Africa Market Value Proportion Analysis, 2022
Figure 321: Global Vs Northern Africa Growth Comparison, 2022 to 2033
Figure 322: Northern Africa Market Share Analysis (%) by Product, 2022 to 2033
Figure 323: Northern Africa Market Share Analysis (%) by Body Parts, 2022 to 2033
Figure 324: Northern Africa Market Share Analysis (%) by Molecular Weight, 2022 to 2033
Figure 325: Northern Africa Market Share Analysis (%) by Indication, 2022 to 2033
Figure 326: Northern Africa Market Share Analysis (%) by End User, 2022 to 2033
The market registers USD 2.4 billion in revenue in 2023.
The global market revenue is projected to exceed USD 4.0 billion by 2033.
Sales of hyaluronic viscosupplementation is expected to record a 5.2% CAGR through 2033.
Hyaluronic viscosupplementation boasts substantial revenue prospects in Japan.
The market secured USD 2.3 billion revenue in 2022.
Explore Similar Insights
Hyaluronic Viscosupplementation Market
Thank you!
You will receive an email from our Business Development Manager. Please be sure to check your SPAM/JUNK folder too.
